MATTHEW COHEN: Open Payments
NPI 1437219748 · CHESTER, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$357 in 17 payments from 9 companies in 2025. Trend: 2023 $730 · 2024 $872 · 2025 $357
Food & beverage: $357
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $91 |
| GlaxoSmithKline, LLC. | 4 | $88 |
| Novo Nordisk Inc | 3 | $58 |
| ABBVIE INC. | 1 | $28 |
| Dexcom, Inc. | 1 | $22 |
| Exact Sciences Corporation | 1 | $22 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $20 |
| PFIZER INC. | 1 | $15 |
| Lilly USA, LLC | 1 | $14 |
Products named: XIFAXAN, TRELEGY ELLIPTA, Ozempic, JARDIANCE, UBRELVY, Rybelsus, Dexcom G6 Transmitter, The Cologuard Plus Collection Kit.
Industry payments across PA — which companies pay providers there.
